Search

everythinglearnresearchcommunity

for

Search:↓

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Dr. Michael Beehner recommends a personalized, careful approach to hairline design in hair replacement surgery for a natural look.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.